Collplant

CollPlant is involved in the development and commercialization of proteins produced in its plant expression and production system.

Working for a Better, Healthier Tomorrow: CollPlant is a medical device company focused on advancing regenerative medicine by utilizing its proprietary processing technologies for human collagen and other recombinant proteins. The company is developing a substantial range of biomaterials-based products applicable in multiple medical markets, including orthopaedics, wound management, cardiology and general surgery. Innovative Production for Advanced Performance: CollPlant’s groundbreaking plant based production system provides the only source of commercially available virgin human collagen. Virgin collagen provides inherently exceptional performance, structural homogeneity and safety, ideal for collagen-based medical devices. Expanding Collagen Applications: From its enhanced virgin collagen, CollPlant is developing a family of products that offers an unprecedented range of scaffolds. including sheets, sponges, gels, meshes, microsphere and compounds. Beginning with wound management and orthopedics products, CollPlant plans to offer solutions for soft and hard tissue repair in diverse applications. CollPlant’s plant based production system offers an extensive pipeline of high value, recombinant human collagen derivatives and composites that can be customized for specific applications. Collagen is the primary building block of the human body. Its biocompatibility, biodegradability and low immunogenicity make it an ideal choice for pharmaceutical and biotechnological applications. CollageTM, the first plant-derived source of type I recombinant human collagen, offers excellent homogeneity, contouring abilities and scaffolding properties.